HAEMONETICS CORP's ticker is HAE and the CUSIP is 405024100. A total of 298 filers reported holding HAEMONETICS CORP in Q1 2021. The put-call ratio across all filers is 0.53 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2021 | $8,473,000 | -81.5% | 127,147 | -69.2% | 0.17% | -82.4% |
| Q1 2021 | $45,760,000 | -13.7% | 412,218 | -7.7% | 0.97% | -20.1% |
| Q4 2020 | $53,050,000 | +31.0% | 446,735 | -3.8% | 1.21% | +17.9% |
| Q3 2020 | $40,507,000 | +39.4% | 464,265 | +43.2% | 1.03% | -3.7% |
| Q2 2018 | $29,065,000 | -43.4% | 324,102 | -53.8% | 1.07% | -40.4% |
| Q1 2018 | $51,356,000 | +18.8% | 701,972 | -5.7% | 1.79% | +17.2% |
| Q4 2017 | $43,244,000 | +26.5% | 744,564 | -2.3% | 1.53% | +23.9% |
| Q3 2017 | $34,189,000 | +11.7% | 761,951 | -1.7% | 1.23% | +10.1% |
| Q2 2017 | $30,601,000 | +37.9% | 774,906 | +41.7% | 1.12% | +45.3% |
| Q1 2017 | $22,190,000 | +46.4% | 546,965 | +45.0% | 0.77% | +33.9% |
| Q4 2016 | $15,160,000 | -28.1% | 377,115 | -35.2% | 0.58% | -18.7% |
| Q3 2016 | $21,074,000 | -19.7% | 581,983 | -35.7% | 0.71% | +6.3% |
| Q2 2016 | $26,249,000 | -17.7% | 905,466 | -0.6% | 0.66% | -13.1% |
| Q1 2016 | $31,875,000 | +10.3% | 911,234 | +1.7% | 0.76% | +4.7% |
| Q4 2015 | $28,886,000 | -3.4% | 895,959 | -3.1% | 0.73% | -4.2% |
| Q3 2015 | $29,891,000 | -22.7% | 924,839 | -1.1% | 0.76% | -12.2% |
| Q2 2015 | $38,661,000 | -9.5% | 934,751 | -1.8% | 0.87% | -6.2% |
| Q1 2015 | $42,738,000 | +12.2% | 951,433 | -6.6% | 0.93% | +20.1% |
| Q4 2014 | $38,106,000 | +3.8% | 1,018,325 | -3.1% | 0.77% | +1.7% |
| Q3 2014 | $36,703,000 | -6.8% | 1,051,053 | -5.8% | 0.76% | -0.1% |
| Q2 2014 | $39,375,000 | +8.0% | 1,116,076 | -0.3% | 0.76% | +4.5% |
| Q1 2014 | $36,470,000 | -22.2% | 1,119,060 | +0.6% | 0.73% | -21.9% |
| Q4 2013 | $46,864,000 | +2.3% | 1,112,360 | -3.1% | 0.93% | -5.8% |
| Q3 2013 | $45,792,000 | -8.5% | 1,148,233 | -5.1% | 0.99% | -7.9% |
| Q2 2013 | $50,048,000 | – | 1,210,348 | – | 1.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Iron Triangle Partners LP | 330,000 | $36,633,000 | 4.66% |
| BEACONLIGHT CAPITAL, LLC | 156,395 | $17,361,000 | 2.80% |
| Bridge City Capital, LLC | 48,011 | $5,330,000 | 1.77% |
| Summit Creek Advisors LLC | 121,362 | $13,472,000 | 1.61% |
| Sivik Global Healthcare LLC | 25,000 | $2,775,000 | 1.01% |
| ANCHOR CAPITAL ADVISORS LLC | 412,218 | $45,760,000 | 0.97% |
| MESIROW FINANCIAL INVESTMENT MANAGEMENT - Fixed Income | 69,655 | $7,732,000 | 0.90% |
| Orbimed Advisors | 852,000 | $94,581,000 | 0.88% |
| LONDON CO OF VIRGINIA | 1,057,738 | $117,420,000 | 0.67% |
| WEXFORD CAPITAL LP | 40,138 | $4,456,000 | 0.66% |